Cardiac Fibroblast to Myofibroblast Phenotype Conversion—An Unexploited Therapeutic Target
Fibrosis occurs when the synthesis of extracellular matrix outpaces its degradation, and over time can negatively impact tissue and organ function. In the case of cardiac fibrosis, contraction and relaxation of the heart can be impaired to the point of precipitating heart failure, while at the same...
Main Author: | Michael P. Czubryt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Journal of Cardiovascular Development and Disease |
Subjects: | |
Online Access: | https://www.mdpi.com/2308-3425/6/3/28 |
Similar Items
-
Mechanical and Physical Regulation of Fibroblast–Myofibroblast Transition: From Cellular Mechanoresponse to Tissue Pathology
by: Mirko D'Urso, et al.
Published: (2020-12-01) -
Editorial: Pulmonary fibrosis and lung carcinogenesis: do myofibroblasts and cancer-associated fibroblasts share a common identity?
by: Daniela de Totero, et al.
Published: (2024-03-01) -
Cardiac fibroblasts in heart failure and regeneration
by: Alenca Harrington, et al.
Published: (2024-04-01) -
Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease
by: Caitlin Hall, et al.
Published: (2021-03-01) -
Fibroblasts in fibrosis: novel roles and mediators
by: Ryan Thomas Kendall, et al.
Published: (2014-05-01)